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and whole cell lysates (WCE) were prepared. Endogenous IFNAR1 was immunoprecipitated and analyzed by IB using anti-pS535 and anti-IFNAR1 (R1)
antibodies. WCE were analyzed by immunoblotting using the indicated antibodies. Studies on HCV were carried out using HCV genomic and subgenomic replicon system.
Stable derivatives of Huh7 human hepatic cell line that express either incomplete genome of HCV (lacking structural proteins) or complete HCV genome (that expresses structural proteins as well) were generated and characterized as previously described (Luquin et al., 2007) .
In vitro kinase assay:
In vitro PERK kinase assay using GST-cIFNAR1 as a substrate was performed using kinase buffer containing 20 mM HEPES 7.4, 50 mM KCl, 2 mM MgOAC, 2 mM MnCl 2 , 20 μM ATP and 1.5 mM DTT. Recombinant PERK ΔN and GST-IFNAR1 were described previously (Cullinan et al., 2003; Kumar et al., 2003) . 5 ng of PERK ΔN and 1 µg of GST-IFNAR1 was mixed in the kinase buffer containing 1 μCi of γ-ATP. The reaction mix was incubated at 30 o C for 30 min. The samples were separated on SDS-PAGE and analyzed by auto-radiography.
Virus-mediated shRNA knockdown:
Virus packaging was done in 293T cells as described elsewhere (Dull et al., 1998) ..
Target cells were infected with concentrated virus in the presence of 3 μg/ml of polybrene. 48 h after transduction, 2fTGH and 293T cells were selected in medium containing 1.5 and 3 μg/ml of puromycin, respectively.
Antibodies:
Antibodies against pSTAT1, p-eIF2α, p-β-catenin, IRE1α (Cell Signaling), STAT1 (Cell Signaling), eIF2α (Biosources), hIFNAR1, PKR, c-Jun (Santa Cruz), β-actin (Sigma)
were used in immuno-precipitation or immunoblotting experiments. Anti-pS535 was previously described (Kumar et al., 2004) . Anti-serum against PERK was generated using recombinant PERK. Monoclonal antibody 23H12, specific for the M protein of VSV (VSV-M), was kindly provided by D. S. Lyles (Wake Forest University). Blocking antibodies against human IFNα and IFNβ were purchased (PBL).
FACS analysis:
Measurements of surface levels of IFNAR1 in MEFs of various genetic background was carried out using an anti-mIFNAR1 antibody (R&D Services) as previously described elsewhere (Sheehan et al., 2006) .
Viral titer determination:
MEFs were infected with an apparent MOI0.1 of VSV for 1 h before the initial inoculum was removed and the cell layer was fed with medium after washed once with PBS. 20 h after infection, the virus-containing culture supernatant was harvested and the viral titer is determined according to previously published report (Sharma et al., 2003) . At the time of
